Skip to content
OpenCapital
Get started

IDEX IEX Health & Science Technologies — Net Sales

Other segment segments

Fluid & Metering Technologies
$301.5M+3.8%
Fire & Safety/Diversified Products
$188.3M+2.2%

Similar metrics at other companies

Baxter International logo
BAXHealthcare Systems & Technologies — Net Sales
$705M+0.1%
DuPont de Nemours, Inc. logo
DDHealthcare Technologies — Net Sales
$467M+11.5%
International Flavors & Fragrances logo
IFFHealth & Biosciences — Net Sales
$595M+10.2%
DuPont de Nemours, Inc. logo
DDHealthcare & Water Technologies — Net Sales
$806M+5.6%
AVT
AVTRBioscience & Medtech Products — Net Sales
$431.4M+1.2%
Materion logo
MTRNLife sciences — Net Sales
-$1.53M-113%

Other financials

Income statement

See full
Revenue$886.9M+8.9%
Gross profit$398.1M+7.9%
Operating income$172.4M+21.4%
Net income$120.0M+25.7%
EPS (diluted)$1.61+27.8%

Balance sheet

See full
Cash & equivalents$591.8M-3.3%
Total debt$1.9B-3.4%
Total equity$4.0B+3.7%
Total assets$6.9B+1.8%

Cash flow

See full
Operating cash flow$103.7M-1.9%
CapEx$17.7M+23.8%
Free cash flow$86.0M-5.9%

Valuation

See full
Market cap$16.49B+18.4%
Enterprise value$17.79B+16.8%
P/E32.5×+2.8×
P/S4.7×+0.5×

Profitability

See full
Gross margin44.4%0.0pp
Operating margin20.7%+0.6pp
Net margin14.4%-0.2pp
FCF margin17.3%+0.3pp

Returns & leverage

See full
Return on equity12.8%0.0pp
Debt / equity0.5×0.0×
Current ratio3.4×+0.6×

Where this comes from

Reported directly by IDEX in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: IDEX’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about IDEX's health & science technologies — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is IDEX's health & science technologies — net sales?
IDEX (IEX) reported health & science technologies — net sales of $398.4M in Q1 2026.
How has IDEX's health & science technologies — net sales changed year-over-year?
IDEX's health & science technologies — net sales increased by 16.7% year-over-year, from $341.5M to $398.4M.
What is the long-term trend for IDEX's health & science technologies — net sales?
Over 4 years (2021 to 2025), IDEX's health & science technologies — net sales has grown at a 7.5% compound annual growth rate (CAGR), from $1.12B to $1.5B.
What does health & science technologies — net sales mean?
Represents the total revenue generated from the sale of products and services within the Health and Science Technologies business segment. This includes specialized fluidic systems, precision components, and analytical instruments sold to life science and medical end markets.